A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

NCT04836559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Onset Seizures

Interventions

DRUG: JNJ-40411813
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC